| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |